Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

about

Pro-necrotic molecules impact local immunosurveillance in human breast cancer.Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance

P2860

Q42509779-AC6885A8-384A-4945-BBC2-7CADE95D4983 Q58729482-876B0435-B6E2-4F11-9014-8FF867DEA444

P2860

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

Item

http://www.wikidata.org/entity/Q36060217

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

@ast

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

@en

type

Item

label

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

@ast

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

@en

prefLabel

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

@ast

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

@en

P1476

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

@en

P2093

Antonella Sistigu

http://www.w3.org/2001/XMLSchema#string

P2860

Immunogenic cell death in cancer therapy

Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress.

TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR(+) head and neck cancer cells.

The secret ally: immunostimulation by anticancer drugs.

Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance.

CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy.

Chemotherapy engages multiple pathways leading to IL-1β production by myeloid leukocytes.

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

Immunogenic cell death inducers as anticancer agents.

P304

e988042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/2162402X.2014.988042

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26405588

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

4570096

http://www.w3.org/2001/XMLSchema#string

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

about

P2860

P2860

Autocrine signaling of type 1 interferons in successful anticancer chemotherapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932